Cargando…
Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection
Human respiratory syncytial virus (HRSV) is a leading cause of death in young children and there are no FDA approved vaccines. Bovine RSV (BRSV) is antigenically similar to HRSV, and the neonatal calf model is useful for evaluation of HRSV vaccines. Here, we determined the efficacy of a polyanhydrid...
Autores principales: | Maina, Teresia W., Grego, Elizabeth A., Broderick, Scott, Sacco, Randy E., Narasimhan, Balaji, McGill, Jodi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289034/ https://www.ncbi.nlm.nih.gov/pubmed/37359514 http://dx.doi.org/10.3389/fimmu.2023.1186184 |
Ejemplares similares
-
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf
por: McGill, Jodi L., et al.
Publicado: (2018) -
Applications of Nanovaccines for Disease Prevention in Cattle
por: Maina, Teresia W., et al.
Publicado: (2020) -
A single dose polyanhydride-based nanovaccine against paratuberculosis infection
por: Thukral, Akanksha, et al.
Publicado: (2020) -
Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry
por: Renu, Sankar, et al.
Publicado: (2018) -
Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells
por: Banerjee, Kasturi, et al.
Publicado: (2019)